MedTrace Logo

Effects of Hip Strengthening Training in Volleyball Players

NCT05998070 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-10-28

No results posted yet for this study

Summary

In order to examine the effects of hip strength training on upper extremity function and performance, 60 healthy volleyball players with an age range of 13 to 40 years will be included in our study. Shoulder joint range of motion, shoulder and hip muscle strength, upper extremity functional performance, and spike speed will be evaluated. Participants will be randomly divided into 2 groups as Training Group (TG) (will receive 6-week, 3 days a week, hip strength training in addition to their sport-specific training) and Control Group (CG) (will continue their sport-specific training).

Evaluations will be repeated 3 times before exercise training, after 6 weeks of exercise training, and at the 12th week, and the results will be analyzed.

Conditions

  • Volleyball
  • Healthy

Interventions

OTHER

Training group

Hip strengthening exercises will be performed 3 times a week for 6 weeks in the training group. 3 exercises consisting of 2 sets and 10 repetitions will be performed every week. A rest interval will be given between sets.

Sponsors & Collaborators

  • Dokuz Eylul University

    lead OTHER

Principal Investigators

  • Sevgi Sevi YESİLYAPRAK, PHD, PT · Dokuz Eylul University Department of Physiotherapy and Rehabilitation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-27
Primary Completion
2024-01-30
Completion
2024-01-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05998070 on ClinicalTrials.gov